{
    "Trade/Device Name(s)": [
        "Alere\u2122 i Instrument",
        "Alere\u2122 i Influenza A & B",
        "Alere\u2122 i Strep A"
    ],
    "Submitter Information": "Alere Scarborough, Inc.",
    "510(k) Number": "K151690",
    "Predicate Device Reference 510(k) Number(s)": [
        "K141520",
        "K141757"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OOI",
        "OCC",
        "OZE",
        "PGX"
    ],
    "Summary Letter Date": "June 22, 2015",
    "Summary Letter Received Date": "June 23, 2015",
    "Submission Date": "July 14, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.2570",
        "21 CFR 866.3980",
        "21 CFR 866.2680"
    ],
    "Regulation Name(s)": [
        "Instrumentation for clinical multiplex test systems",
        "Respiratory viral panel multiplex nucleic acid assay",
        "Groups A, C and G Beta Hemolytic Streptococcus nucleic acid amplification system"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Influenza A viral RNA",
        "Influenza B viral RNA",
        "Streptococcus pyogenes nucleic acid (Group A Streptococcus)"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Throat swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Alere\u2122 i Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Isothermal nucleic acid amplification"
    ],
    "Methodologies": [
        "Molecular amplification",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Instrument",
        "Assay",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Alere\u2122 i Instrument software modification enabling Alere\u2122 i Influenza A & B and Alere\u2122 i Strep A molecular diagnostic assays using isothermal nucleic acid amplification.",
    "Indications for Use Summary": "Alere\u2122 i Influenza A & B: Qualitative detection and discrimination of influenza A and B viral RNA in nasal swabs from symptomatic patients; Alere\u2122 i Strep A: Qualitative detection of Streptococcus pyogenes nucleic acid in throat swabs to aid in diagnosis of Group A Streptococcus infections.",
    "fda_folder": "Clinical Chemistry"
}